Quick Takeaways
- Neil Exter has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,317,951.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Neil Exter
- Location
- Boston, MA
- Summary
- The estimated net worth of Neil Exter is at least $1,317,951 dollars as of 24 Sep 2025. Neil Exter is the Director of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $1.32M.
- Signature
- /s/ Courtney Phillips, as attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Neil Exter and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Revolution Medicines, Inc. ($1,317,951).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Neil Exter
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RVMD, RVMDW | Revolution Medicines, Inc. | Director | $1,317,951 | 16 Jun 2022 | ||
| DBTX | Decibel Therapeutics, Inc. | Director, 10%+ Owner | 17 Jun 2022 | |||
| MAZE | Maze Therapeutics, Inc. | Director | 22 Sep 2025 | |||
| PLRX | PLIANT THERAPEUTICS, INC. | Director | 16 Jun 2022 |
Insider Transactions Reported by Neil Exter:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.